Rapid fluid extraction with the Gambro Ultradiffuser.

Area of Science:

• Nephrology
• Renal Replacement Therapy

Background:

• Fluid overload is a common complication in patients requiring renal replacement therapy.
• Effective fluid management is crucial for patient outcomes.

Purpose of the Study:

• To evaluate the efficacy and safety of the Gambro Ultradiffuser for fluid removal in patients undergoing dialysis.
• To assess the impact of the ultrafiltration and dialysis process on physiological parameters.

Main Methods:

• Four patients received fourteen treatments using the Gambro Ultradiffuser.
• A protocol involving one hour of isolated ultrafiltration followed by four hours of dialysis was employed.
• Transmembrane pressure (TMP) was manipulated to achieve distinct ultrafiltration rates during different phases.

Main Results:

• Mean fluid removal was 2678 ml per ultrafiltration period, with a mean ultrafiltration rate of 37 ml/min (up to 49 ml/min).
• Significant increases were observed in hematocrit (3%), plasma protein (21%), and plasma albumin (25%).
• No significant changes were noted in plasma electrolytes, urea, creatinine, or osmolality. Mean arterial pressure remained stable despite variations. Three patients experienced side effects, including reversible hearing loss, cardiac arrhythmias, and hypertension.

Conclusions:

• The Gambro Ultradiffuser facilitates rapid and effective fluid removal.
• The treatment leads to hemoconcentration, with generally stable biochemical parameters.
• While effective, careful monitoring is necessary due to potential reversible adverse events.